Chembio Diagnostics Inc (CEMI)

[GeoMoney1]

SBU to use LI firm's antibody test in convalescent plasma research

A Hauppauge manufacturer is supplying diagnostic tests to Stony Brook University for a 500-person study to see if the blood of coronavirus survivors can help those critically ill with the virus, officials said.
Chembio Diagnostics Inc. announced its rapid coronavirus test will be used by researchers at Stony Brook’s Renaissance School of Medicine to identify people who have recovered from the virus and whose blood contains antibodies that could serve as a treatment. The school is purchasing the test, a university spokeswoman said Monday.
Stony Brook is among at least four hospital systems on Long Island launching clinical trials on the use of convalescent plasma to stop the infection in others or prevent the infection.
Chembio received an “emergency use authorization” to sell the 15-minute test from the federal Food and Drug Administration this month -- around the time that the agency approved the Stony Brook clinical trial.

https://www.newsday.com/business/coronavirus/chembio-stony-antibody-test-1.43836089